Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


T3™ Conjugation Kit

Product Description
One of the hurdles to delivering RNAi effectively includes being able to deliver siRNA into specific cells and organs. Using the T3™ Conjugation Kit, based on Bioo Scientific’s patent pending Targeted Transport Technology, scientists can administer siRNA to target cells and tissues using both in vivo and in vitro models. The T3 Conjugation Kit lets scientists deliver siRNA or miRNA into any cell type they want by conjugating the T3 carrier to an antibody that is specific to a receptor or other extracellular domain specific to the cell or tissue type they want to target. The T3 procedure does not require any prior modifications of the antibody or the RNAi agent and can be performed in a few simple steps. T3™ Conjugation Kit Procedure 1. Identify an antibody that is specific to a receptor specific to your targeted cell type 2. Conjugate the antibody to the T3 Carrier 3. Load the T3 Conjugate with siRNA or miRNA 4. Administer to animal or transfect cell lines 5. T3 Conjugate is taken up by targeted cells 6. The siRNA or miRNA is released inside the targeted cells Selected References: Goodchild, J (2011) Therapeutic Oligonucleotides: Methods and Protocols. Humana Press 1st Edition.
Product T3™ Conjugation Kit
Company BIOO Scientific - Product Directory
Price Request a quote
More Information View company product page
Catalog Number 5150
Quantity 15 - 20 injections
Company Logo

BIOO Scientific - Product Directory
3913 Todd Lane Suite 312 Austin, TX 78744, USA

Tel: +1 512-707-8993
Fax: +1 512-707-8122
Email: info@biooscientific.com



Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!